1-ethyl-3-(3-dimethylaminoethyl)carbodiimide has been researched along with bremazocine in 1 studies
Studies (1-ethyl-3-(3-dimethylaminoethyl)carbodiimide) | Trials (1-ethyl-3-(3-dimethylaminoethyl)carbodiimide) | Recent Studies (post-2010) (1-ethyl-3-(3-dimethylaminoethyl)carbodiimide) | Studies (bremazocine) | Trials (bremazocine) | Recent Studies (post-2010) (bremazocine) |
---|---|---|---|---|---|
68 | 0 | 10 | 323 | 0 | 4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnard, EA; Richardson, A; Simon, J | 1 |
1 other study(ies) available for 1-ethyl-3-(3-dimethylaminoethyl)carbodiimide and bremazocine
Article | Year |
---|---|
Protection by opioid ligands against modification of the opioid receptor by a carbodiimide.
Topics: Animals; Benzeneacetamides; Benzomorphans; Binding Sites; Brain Chemistry; Carbodiimides; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine-2-Alanine; Enkephalins; Guanylyl Imidodiphosphate; Guinea Pigs; Pyrrolidines; Receptors, Opioid | 1992 |